SCHEDULE: Barclays PLC Reports Stake in Penumbra Inc.

Barclays PLC has updated its beneficial ownership filing for Penumbra Inc., reporting a 5.95% stake as of June 30, 2026.

Summary

• Barclays PLC has filed a Schedule 13G, indicating a change in its beneficial ownership of Penumbra Inc. common stock.
• As of June 30, 2026, Barclays PLC beneficially owns 2,342,118 shares of Penumbra Inc. common stock.
• This represents 5.95% of the class of securities.
• The filing indicates Barclays PLC has sole voting power over 2,340,999 shares and shared voting power over 1,119 shares.
• Similarly, Barclays PLC has sole dispositive power over 2,340,999 shares and shared dispositive power over 1,119 shares.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without disclosing new strategic or financial performance information.

Positives

• Barclays PLC's investment indicates confidence in Penumbra Inc.'s long-term prospects, as it is a significant stake.
• The filing is a routine disclosure, suggesting no immediate negative events or concerns from Barclays PLC's perspective.

Negatives

• The filing does not provide any new financial performance data or strategic updates for Penumbra Inc.
• The increase or decrease in stake is not detailed, only the current position is reported.

Risks

• Changes in beneficial ownership by large institutional investors like Barclays PLC can sometimes precede or follow significant market movements or strategic shifts, though this filing does not specify the reason for the current stake.
• A significant stake held by a financial institution could lead to increased scrutiny or potential influence on corporate governance decisions.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding Penumbra Inc.'s future performance.

Management Comments

• Ramya Rao, Director at Barclays PLC, certified that the information is true, complete, and correct, and that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Industry Context

StockSavvy.ai notes that institutional ownership filings like this are common in the healthcare technology sector, reflecting the active role of financial institutions in monitoring and investing in publicly traded companies. Barclays PLC's filing indicates a notable position in Penumbra Inc., a company operating in the neurovascular and peripheral vascular markets.

Comparison to Industry Standards

• As a Schedule 13G filing, this is a standard disclosure for significant beneficial ownership by institutional investors. The 5.95% stake is substantial and places Barclays PLC among the significant shareholders of Penumbra Inc.
• Industry standards for institutional ownership vary by sector, but a stake of this size typically signifies a passive investment strategy unless otherwise stated.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding a significant institutional investor's stake, which can influence market perception and trading activity.
• Management: Penumbra Inc.'s management will be aware of Barclays PLC's ownership level, which is standard practice.

Next Steps

• Barclays PLC will continue to monitor its holdings in Penumbra Inc. and may file amendments to this Schedule 13G if there are further changes in beneficial ownership.
• Penumbra Inc. will continue its operations and financial reporting as usual.

Key Dates

Keywords

Barclays PLC, Penumbra Inc., Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Securities Exchange Act